Healthcare provider profile · identity verified

John E Poff, MD

Internal Medicine · NEW YORK, NY · NPI 1619979259

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	213	68
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	183	60
Albuterol Sulfate Hfa	Albuterol Sulfate	149	44
Metformin Hcl	Metformin Hcl	139	46
Amlodipine Besylate	Amlodipine Besylate	126	41
Lisinopril	Lisinopril	116	39
Levothyroxine Sodium	Levothyroxine Sodium	108	28
Fluticasone Propionate	Fluticasone Propionate	105	40
Losartan Potassium	Losartan Potassium	96	34
Omeprazole	Omeprazole	93	32
Jardiance	Empagliflozin	89	23
Zolpidem Tartrate	Zolpidem Tartrate	86	30
Hydrochlorothiazide	Hydrochlorothiazide	72	21
Chlorthalidone	Chlorthalidone	71	26
Ramipril	Ramipril	67	21
Ibuprofen	Ibuprofen	61	19
Januvia	Sitagliptin Phosphate	59	14
Simvastatin	Simvastatin	59	22
Gabapentin	Gabapentin	50	20
Nifedipine Er	Nifedipine	50	19
Tamsulosin Hcl	Tamsulosin Hcl	50	22
Meloxicam	Meloxicam	48	19
Metoprolol Succinate	Metoprolol Succinate	44	15
Tramadol Hcl	Tramadol Hcl	44	11
Meclizine Hcl	Meclizine Hcl	43	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	42	11
Famotidine	Famotidine	41	16
Prednisone	Prednisone	41	18
Naproxen	Naproxen	37	14
Alendronate Sodium	Alendronate Sodium	36	12
Ammonium Lactate	Ammonium Lactate	35	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	35	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	35	11
Alcohol Prep Pads	Alcohol Antiseptic Pads	34	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	34	16
Clopidogrel	Clopidogrel Bisulfate	34	suppressed
Allopurinol	Allopurinol	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	11
Montelukast Sodium	Montelukast Sodium	31	11
Ozempic	Semaglutide	31	suppressed
Oxycodone Hcl	Oxycodone Hcl	30	13
Folic Acid	Folic Acid	28	11
Clonazepam	Clonazepam	27	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	27	suppressed
Alprazolam	Alprazolam	26	18
Ezetimibe	Ezetimibe	26	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Potassium Chloride	Potassium Chloride	26	suppressed
Azelastine Hcl	Azelastine Hcl	25	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	25	suppressed
Lorazepam	Lorazepam	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Furosemide	Furosemide	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	16
Eliquis	Apixaban	21	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	21	suppressed
Morphine Sulfate	Morphine Sulfate	21	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Atenolol	Atenolol	19	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Mupirocin	Mupirocin	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Trazodone Hcl	Trazodone Hcl	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Nyamyc	Nystatin	12	suppressed
Nystatin	Nystatin	12	suppressed
Atrovent Hfa	Ipratropium Bromide	11	suppressed
Brilinta	Ticagrelor	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error